tiprankstipranks
Akebia Therapeutics (CH:AX9)
:AX9
Switzerland Market

Akebia Therapeutics (AX9) Earnings Dates, Call Summary & Reports

0 Followers

Earnings Data

Report Date
Oct 29, 2026
After Close (Confirmed)
Period Ending
2026 (Q3)
Consensus EPS Forecast
-0.03
Last Year’s EPS
0
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings

Akebia Therapeutics (CH:AX9) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CH:AX9 Q2 2026 Earnings Report

CH:AX9 Upcoming Earnings
Akebia Therapeutics's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

CH:AX9 Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 29, 2026
2026 (Q3)
-0.03 / -
0
2026 (Q2)
-0.03 / -0.02
0
2026 (Q1)
-0.02 / -0.02
0.024-200.00% (-0.05)
2025 (Q4)
-0.03 / -0.04
-0.08150.00% (+0.04)
2025 (Q3)
>-0.01 / 0.00
-0.081
2025 (Q2)
-0.01 / 0.00
-0.032
2025 (Q1)
-0.03 / 0.02
-0.073133.33% (+0.10)
2024 (Q4)
-0.07 / -0.08
0
2024 (Q3)
-0.05 / -0.08
-0.065-25.00% (-0.02)
2024 (Q2)
-0.06 / -0.03
-0.04933.33% (+0.02)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

FAQ

When does Akebia Therapeutics (CH:AX9) report earnings?
Akebia Therapeutics (CH:AX9) is schdueled to report earning on Oct 29, 2026, After Close (Confirmed).
    What is Akebia Therapeutics (CH:AX9) earnings time?
    Akebia Therapeutics (CH:AX9) earnings time is at Oct 29, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Akebia Therapeutics stock?
          The P/E ratio of Akebia Therapeutics is N/A.
            What is CH:AX9 EPS forecast?
            CH:AX9 EPS forecast for the fiscal quarter 2026 (Q3) is -0.03.